Our brands & services
Market access
& HEOR
This department offers decision tools to allow decision-makers in choosing the best health strategies, whether for drugs, medical devices, or diagnostic tests. Our interdisciplinary team assists manufacturers in collecting the relevant clinical and health economic data needed to secure fair pricing and reimbursement for their innovation in key European markets.
We also support manufacturers in communicating the value of new products to multiple stakeholders, though an all-encompassing view of clinical efficacy, real-world data, and opportunity costs of various intervention mixes, budget impact, and cost-effectiveness models.
Our solutions
PRICING & REIMBURSEMENT
SUBMISSIONS TO HTA AGENCIES
CLINICAL EVIDENCE VS. ECONOMIC MODELS
BUDGET IMPACT ANALYSIS
ANALYTIC MODELLING & DECISION-MAKING
MICRO-COSTING ANALYSES
HANDLING OF NATIONAL DATABASES
SYSTEMATIC REVIEW AND META-ANALYSES
Resources
Senior scientific director
Health economist
Biostatisticians
Epidemiologist
Activities
Pricing & Reimbursement dossiers
Submissions to HTA agencies
Modeling (Markov, Microsimulation, DES, etc.)
Multi-Criteria Decision-Analysis, Decision Tree Analysis, etc.
Database handling (PMSI, NHS, etc.)
Network meta-analysis